Skip to content

Canceled by the investigator. Construction and effectiveness evaluation of disease admission plan for new hemodialysis patients based on doctor-patient shared decision-making model

Construction and effectiveness evaluation of disease admission plan for hemodialysis patients based on doctor-patient shared decision-making model

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076382
Enrollment
Unknown
Registered
2023-10-07
Start date
2023-10-08
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

control group:Accept routine dialysis management, with doctors formulating and adjusting treatment plans, and nurses providing health guidance and routine care.
experimental group:Accept disease admission management solutions based on the doctor-patient shared decision-making (SDM) model.

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed by western medicine as chronic renal failure uremic stage, aged 18-60 years old; 2. Within 12 months of regular dialysis, and the condition is stable; Dialysis is performed 3 times a week, with a duration of 3.5-4 hours each time. The dialyzer uses a Fresenius 4008S dialyzer, with a dialysate flow rate of 500ml/min and a blood flow rate of 260-280ml/min. The dialyzer uses Fresenius Fx80 and online dialyzer B dry powder (HND-TDB01); 3. Have normal reading, writing, and communication skills; Able to use smartphones and have network support; 4. Informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: 1. Unclear language expression or communication barriers; 2. The patient has participated or is currently participating in other forms of psychological intervention; 3. Any other reasons deemed unsuitable by the researcher (such as incomplete cases and concurrent peritoneal dialysis).

Design outcomes

Primary

MeasureTime frame
Disease acceptance;life quality, SF-36;Residual renal function;blood electrolyte;

Secondary

MeasureTime frame
Biochemical indicators;SF-36 Scale Rating;Residual renal function retention time;

Countries

China

Contacts

Public ContactHan Xintong

The First Hospital of Jilin University

905785747@qq.com+86 158 0430 1299

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026